Moreover, the relationship between Ki-67 and KRAS-mutant status in NSCLC, Woo et al. (36) showed that the expression of Ki-67 and the KRAS mutation status is significantly correlated with stage I LUAD. Here, KRAS is linked to non-small cell lung carcinoma.